Prometheus therapy in patients with acute liver failure – the effect on the inflammation and regeneration markers
Authors:
Ročeň Milan 1; Kieslichová Eva 1; Merta Dušan 1; Pavlova Jelena 2; Čáp Jiří 1; Trunečka Pavel 3
Authors place of work:
Klinika anesteziologie, resuscitace a intenzivní péče, Transplantcentrum IKEM, Praha
1; Oddělení imunogenetiky, Pracoviště laboratorních metod IKEM, Praha
2; Transplantcentrum IKEM, Praha
3
Published in the journal:
Anest. intenziv. Med., 21, 2010, č. 4, s. 199-205
Category:
Original Article
Summary
Objective:
Prometheus, a device based on modified fractionated plasma separation and adsorption, is used in the therapy of acute liver failure as a bridging to liver transplantation. The therapeutic effect of Prometheus is not limited just to the elimination of terminal metabolites, therefore the aim of the study was to identify the effect of this method on the levels of cytokines and inflammation and liver regeneration markers. The effect on encephalopathy, haemodynamics and time on the waiting list for liver transplantation was also observed.
Materials and methods:
Total 11 patients with acute liver failure were investigated. These patients underwent 37 therapeutic sessions on Prometheus . Before and after each treatment session the serum concentrations of selected cytokines and inflammation and liver regeneration markers were measured, and the kinetics of their serum concentrations were evaluated.
Results:
Before the therapy, elevated levels of some cytokines and inflammation markers were detected. Some of them decreased significantly during the therapy. By contrast, the level of the Hepatocyte Growth Factor was increased. The treatment did improve encephalopathy and time on the waiting list but no effect on the hemodynamics was found.
Conclusion:
Our results show that Prometheus is effective in the clearance of some of the inflammatory mediators and affects the serum levels of the inflammatory and regeneration markers that are important in the therapeutic approach to acute liver failure management.
Keywords:
acute liver failure – cytokines – encephalopathy – inflammatory markers – Prometheus – regeneration
Zdroje
1. O´Grady, J. G., Schalm, S. W., Williams, R. Acute liver failure: Redefining the syndromes. Lancet, 1993, p. 273–275.
2. Sekiyama, K. D., Yoshiba, M., Thomson, A. W. Circulating proinflammatory cytokines (IL-1 beta, TNF-alpha, and IL-6) and IL-1 receptor antagonist (IL1Ra) in fulminant hepatic failure and acute hepatitis. Clin. Exp. Immunol., 1994, p. 71–77.
3. Muto,Y., Nouri-Aria, K. T., Meager, A. et al. Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure. Lancet,1988, p. 72–74.
4. Sheron, N., Goka, J., Wendon, J. A. et al. Highly elevated plasma cytokines in FHF: Correlations with multiorgan failure and death. Hepatology, 1990, p. 939.
5. Simpson, K. J. Cytokines, for better or worse? Eur. J. Gastroenterol. Hepatol., 1999, p. 957–966.
6. O’Grady, J. G., Alexander, G. J., Hayllar, K. M. et al. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology, 1989, p. 439–445.
7. Rifai, K., Ernst, T., Kretschmer, U. et al. Prometheus – new extracoporeal system for treatment of liver failure. J. Hepatol., 2003, p. 984–990.
8. Falkenhagen, D., Strobl, W., Vogt, G. et al. Fractioned plasma separation and adsorption system: A novel system for blood purification to remove albumin bound substance. Artif. Organs, 1999, p. 81–86.
9. Bellomo, R., Tetta, C., Ronco, C. et al. Coupled plasma filtration adsorption. Int. Care Med., 2003, p. 1222–1228.
10. Winchester, J. F., Kellum, J. A., Ronco, C. et al. Sorbents in acute renal failure and the systemic inflammatory response syndrome. Blood Purif, 2003, p. 79–84
11. Tetta, C., Cavaillon, J. M., Schultze, M. et al. Removal of cytokines and activated komplement components in an experimental model of continuous plasma filtration coupled with sorbent adsorption. Nephrol. Dial. Transplant., 1998, p. 1458–1464.
12. Stadlbauer, V., Krisper, P., Aigner, R. et al. Effect of extracorporeal liver support by MARS and Prometheus on serum cytokines in acute-on-chronic liver failure. Critical Care, 2006, p. 169.
13. Rifai, K., Ernst, T., Kretschmer, U. et al. Removal selectivity of Prometheus: A new extracorporeal liver support device. World J. Gastroenterol., 2006, p. 940.
14. Parés, A., Deulofeu, R., Cisneros, L. et al. Albumin dialysis improves hepatic encephalopathy and decreases circulating phenolic aromatic amino acids in patients with alcoholic hepatitis and severe liver failure. Crit. Care, 2009, p. 8.
15. Bustamante, J., Rimola, A., Ventura, J. P. et al. Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J.Hepatol., 1999, p. 890–895.
16. Laleman, W., Wilmer, A., Evenepoel, P. et al. Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure. Crit. Care, 2006, p. 108.
17. Level, C., Chauveau, P., Guisset, O. et al. Mass transfer, clearance and plasma concentration of procalcitonin during continuous venovenous hemofiltration in patients with septic shock and acute oliguric renal failure. Crit. Care, 2003, p. 160–166.
18. Matsushima, A., Ogura, H., Koh, T. et al. Hepatocyte Growth Factor in polymorphonuclear leukocytes is increased in patients with Systemic Inflammatory Response Syndrome. J. Trauma, 2004, p. 259–264.
19. Chamuleau, R. A., Aronson, D. C., Frederiks, W. M. et al. Liver regeneration after partial hepatectomy in rats with defective bilirubin conjugation or biliary excretion. Dig. Dis. Sci., 1991, p. 510–551.
Štítky
Anaesthesiology, Resuscitation and Inten Intensive Care MedicineČlánok vyšiel v časopise
Anaesthesiology and Intensive Care Medicine
2010 Číslo 4
Najčítanejšie v tomto čísle
- Postoperative sore throat
- Prometheus therapy in patients with acute liver failure – the effect on the inflammation and regeneration markers
- Prometheus – a new therapeutic option in liver failure in children
- Brachial plexus fascias